Tirzepatide Yields Sustained Weight Reduction in Obesity, Prediabetes

MONDAY, Nov. 18, 2024-- For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according to a study published online Nov. 13 in...